Similar articles

• First-trimester fetal screening of cystic fibrosis in low-risk population.

  Brambati B, Tului L, Fattore S. Brambati B, et al. Lancet. 1993 Sep 4;342(8871):624. doi: 10.1016/0140-6736(93)91456-v. Lancet. 1993. PMID: 8102758 No abstract available.
• Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.

  Lau TK, Jiang F, Chan MK, Zhang H, Lo PS, Wang W. Lau TK, et al. J Matern Fetal Neonatal Med. 2013 Mar;26(4):434-7. doi: 10.3109/14767058.2012.733768. Epub 2012 Oct 29. J Matern Fetal Neonatal Med. 2013. PMID: 23035860
• First-trimester risk assessment: twin gestations.

  Platt LD. Platt LD. Semin Perinatol. 2005 Aug;29(4):258-62. doi: 10.1053/j.semperi.2005.06.003. Semin Perinatol. 2005. PMID: 16104678 Review.
• [Diagnosis of cystic fibrosis by DNA studies in the first trimester of pregnancy].

  Németi M, Szabó M, Horváth K, Bolodár A, Papp Z. Németi M, et al. Orv Hetil. 1987 Dec 6;128(49):2577-9. Orv Hetil. 1987. PMID: 3481437 Hungarian. No abstract available.
• Down syndrome screening in twins.

  Bush MC, Malone FD. Bush MC, et al. Clin Perinatol. 2005 Jun;32(2):373-86, vi. doi: 10.1016/j.clp.2005.03.001. Clin Perinatol. 2005. PMID: 15922788 Review.